unclassifiable cells and naked/smudged nuclei were annotated as unknown (3,160). Areas with red blood cells and debris within ROIs were carefully circled for exclusion. Challenges we discovered include exhaustively annotating every cell in the ROIs, to avoid bias, which yields higher numbers of cells in the unknown category, and excluding often abundant red blood cells and debris that were intermingled with the nucleated cells of interest. The other main challenges for automating cell counts are detecting and localizing cells with complex and varying morphologies, distinguishing closely packed cells, and employing localizations for cell classification. The large number of classes, subtle interclass differences, and variations in smear preparation and staining (color and contrast) represented additional, distinct obstacles we identified for BMA analysis. Lastly, the collected data set had an imbalanced distribution among classes, which was unavoidable due to the natural uneven distribution of cell types. This creates a problem in training the algorithm, as only a few features are learned from classes that have limited data. We addressed this problem by annotating additional cells from these classes, without the constraint of ROIs, and will use oversampling and augmentation techniques when training the algorithms. Having created a promising training data set, we are testing this exciting new algorithm on another data set with the ultimate goal of devising a reliable, objective method that automates DCCs. Von Willebrand disease (VWD) is the most common bleeding disorders worldwide. However, accurate diagnosis is difficult due to physiological and analytical variability of the von Willebrand factor (VWF) levels. Frequently, patients have to be tested multiple times to reach a definitive diagnosis. In our clinical lab, we receive approximately 150 VWD workups monthly. To test for Von Willebrand disease, we collect two to three aliquots of blood from the same patient at the same time. Each of these aliquots is spun down, aliquoted (plasma separated from RBCs), frozen, and kept for testing at a later time. We studied the reproducibility of duplicate or triplicate aliquots from approximately 100 patients and found strikingly high variability in reproducibility among the aliquots, especially in the VWF ristocetin cofactor (RCo) activity. In approximately 20% of cases, the discrepancy between the aliquots ranges from normal to abnormal. These huge variations were worrisome because they often lead to a change in diagnosis for patients. We determined that these variations could be due to several preanalytical errors such as drawing samples incorrectly, mixing samples inadequately, or in the freezing and thawing of samples before testing. Indeed, we studied these variables and found out that inappropriate mixing followed by freezing/thawing led to a high degree of discrepancy between fresh and frozen/thawed samples. The standard for VWD testing worldwide is to freeze all samples that will not be run within 8 hours of collection and to then thaw those samples at time of testing. We hypothesize that decreasing the number of manipulations during sample processing will improve the reproducibility and accuracy of the results. In our lab, we run VWF antigen and activity every other day and thus we study the stability of plasma from citrated whole blood spun but not separated for up to 48 hours. For our stability study, we used over 40 patient samples that ranged from low to high VWF activity and antigen levels (10%-150%) and correlated the results of the samples that were run fresh vs those run at 48 hours. We observed a very good correlation between the aliquots run fresh (within 8 hours of collection) and aliquots kept at room temperature for up to 48 hours in the original citrated whole blood tube, which were spun down but not aliquoted for both VWF antigen and VWF RCo activity (R 2 values of 99 and 94, respectively). In summary, based on the results obtained from this study, we conclude that in addition to appropriate mixing at time of collection, VWF can remain stable at room temperature for up to 48 hours and still result in the accurate and precise diagnosis of VWD when compared to samples that are run fresh (within 8 hours of collection).
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To Freeze or Not to

Managing Spectral Interferences Using Optical Coagulation Methods
Kendall Cradic, Chris Rosemark, Darci Block, Nikola Baumann; Mayo Clinic, Rochester, MN Background: Both mechanical and optical-based methods are available for measuring prothrombin time (PT) and activated partial thromboplastin time (aPTT). When optical methods are used, interference from hemolysis, lipemia, and icterus is a concern. Hemolysis is generally resolved by re-collection of the specimen. Lipemia and icterus, however, are problematic because laboratory mitigation procedures such as sample dilution cannot be performed for PT and aPTT. Processes for handling these interferences and providing accurate results are needed. The objective of this study was to develop mitigation strategies for lipemic and icteric specimens submitted for PT and aPTT testing using an optical platform. Our aims were to (1) validate centrifugation for reducing lipemia and (2) characterize the magnitude of interference caused by elevated bilirubin. Methods: The proportion of samples received in the laboratory with significant lipemia and icterus was estimated based on retrospective analysis of over 6,000 specimens.
